$KPTI stock has now risen 26% today, according to our price data from Polygon. There has been approximately $3,055,755 of trading volume.
Here is what we see in our data on $KPTI (you can track the company live on Quiver's $KPTI stock page):$KPTI Insider Trading Activity
$KPTI insiders have traded $KPTI stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $KPTI stock by insiders over the last 6 months:
- RICHARD A. PAULSON (President and CEO) has made 0 purchases and 3 sales selling 1,738 shares for an estimated $10,679.
- RESHMA RANGWALA (EVP & Chief Medical Officer) has made 0 purchases and 2 sales selling 827 shares for an estimated $5,208.
- STUART POULTON (EVP, Chief Development Officer) has made 0 purchases and 2 sales selling 592 shares for an estimated $3,413.
- SOHANYA ROSHAN CHENG (EVP & Chief Commercial Officer) sold 325 shares for an estimated $2,089
- MICHAEL MANO (SVP, General Counsel&Secretary) sold 234 shares for an estimated $1,504
- KRISTIN ABATE (Chief Accounting Officer) has made 0 purchases and 3 sales selling 273 shares for an estimated $1,181.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KPTI Hedge Fund Activity
We have seen 1 institutional investors add shares of $KPTI stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PALO ALTO INVESTORS LP removed 324,032 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,396,577
- OSAIC HOLDINGS, INC. added 4,879 shares (+inf%) to their portfolio in Q2 2025, for an estimated $21,028
- CAPROCK GROUP, LLC removed 773 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,891
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KPTI Analyst Ratings
Wall Street analysts have issued reports on $KPTI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 08/12/2025
- RBC Capital issued a "Outperform" rating on 05/13/2025
- Barclays issued a "Overweight" rating on 05/13/2025
To track analyst ratings and price targets for $KPTI, check out Quiver Quantitative's $KPTI forecast page.
$KPTI Price Targets
Multiple analysts have issued price targets for $KPTI recently. We have seen 4 analysts offer price targets for $KPTI in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Michael Ulz from Baird set a target price of $25.0 on 08/12/2025
- Robert Burns from HC Wainwright & Co. set a target price of $27.0 on 07/11/2025
- Brian Abrahams from RBC Capital set a target price of $33.0 on 05/13/2025
- Peter Lawson from Barclays set a target price of $10.0 on 05/13/2025
You can track data on $KPTI on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
